no image available Dickens & Co. "Breathing New Life into Treatment Options: The Risk of Pneumomediastinum in SABR for Lung Metastases" "Unraveling the Unexpected Consequences of Stereotactic Ablative Radiotherapy in Patients with Lung Cancer Metastases" Price: 25.00€